Transcriptomics

Dataset Information

0

MeVa2.1.dOVA is a novel immune-refractory cell line to study tumor immune resistance

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE209731 | GEO | 2023/07/30

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Other MeVa2.1.dOVA is a novel immune-refractory cell line to study tumor immune resistance [exome-seq]
2023-07-30 | GSE209729 | GEO
Transcriptomics MeVa2.1.dOVA is a novel immune-refractory cell line to study tumor immune resistance [RNA-seq]
2023-07-30 | GSE209725 | GEO
Genomics MeVa2.1.dOVA is a novel immune-refractory cell line to study tumor immune resistance
| PRJNA862161 | ENA
Genomics PRDM11: a novel tumor suppressor
2015-03-02 | E-GEOD-56065 | biostudies-arrayexpress
Transcriptomics Bortezomib resistance in CCRF-CEM cell line
2015-11-04 | E-GEOD-74635 | biostudies-arrayexpress
Genomics MeVa2.1.dOVA is a novel immune-refractory cell line to study tumor immune resistance [RNA-seq]
| PRJNA862159 | ENA
Genomics MeVa2.1.dOVA is a novel immune-refractory cell line to study tumor immune resistance [exome-seq]
| PRJNA862165 | ENA
Transcriptomics Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
2016-12-01 | GSE83850 | GEO
Transcriptomics RNA-seq and ATAC-seq of tumor resistance to immune cell attack
2022-05-09 | GSE202305 | GEO
Transcriptomics Blocking TWEAK inhibits tumor growth through inhibition of tumor cell proliferation and survival and by enhancing the host antitumor immune response
2013-09-30 | E-GEOD-42050 | biostudies-arrayexpress